🇦🇺 H5G1.1 in Australia

H5G1.1 (ECULIZUMAB) regulatory status in Australia.

Marketing authorisations

TGA

  • Status: likely_approved

TGA

  • Status: likely_approved

TGA

  • Status: likely_approved

TGA

  • Status: likely_approved

H5G1.1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Australia

Frequently asked questions

Is H5G1.1 approved in Australia?

Yes. TGA has authorised it; TGA has authorised it; TGA has authorised it.

Who is the marketing authorisation holder for H5G1.1 in Australia?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.